Rocket One Inc. (RKTO): Cash & Equivalents
$6.25M
As of 2025-12-31
$7.89M
As of 2026-06-30
-0.9%
3-year compound annual growth
+18.9%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.25M | -11.2% | 2026-03-27, Balance as of period end |
| 2024-12-31 | $7.04M | -24.3% | 2026-03-27, Balance as of period end |
| 2023-12-31 | $9.29M | +44.5% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $6.43M | -24.7% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $8.54M | +224.7% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $2.63M | +55.5% | 2022-03-30, Balance as of period end |
| 2019-12-31 | $1.69M | +498.3% | 2021-03-16, Balance as of period end |
| 2018-12-31 | $282.6K | -77.0% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $1.23M | n/a | 2019-04-01, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Rocket One Inc. (RKTO) | 2025-12-31 | $6.25M | -11.2% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $4.75M | +21.6% |
| Oncolytics Biotech Inc (ONCY) | 2025-12-31 | $5.20M | -53.0% |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | $4.31M | +23.1% |
| Processa Pharmaceuticals, Inc. (PCSA) | 2025-12-31 | $5.54M | +364.8% |
| Dermata Therapeutics, Inc. (DRMA) | 2025-12-31 | $7.52M | +137.9% |
| Matinas BioPharma Holdings, Inc. (MTNB) | 2025-12-31 | $4.00M | -45.1% |
| GT Biopharma, Inc. (GTBP) | 2025-12-31 | $6.81M | +72.4% |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | $1.8K | -16.3% |
Compare RKTO, SILO, ONCY, ENSC side by side · Screen every company in Pharmaceutical Preparations ↗